Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07339787

Diagnosis of Transient Ischemic Attacks in the Emergency Department

Patients presenting a Transient Ischemic Attack (TIA) and admitted to the Emergency Department should be referred to a neurovascular specialist. In recent years, several hospitals have established TIA clinics. These units are day hospitals where all the necessary examinations are performed. Access to this expertise has proven beneficial in reducing cardiovascular morbidity and mortality, particularly the risk of early recurrence. Unfortunately, this access is limited by issues of medical demographics and unequal access to the healthcare system. In practice, this ideal care is not always possible. A portion of the TIA population is at low risk, and diagnostic and therapeutic interventions are limited, not always requiring neurovascular expertise.

The hypothesis of this research is that the management of a patient who has suffered a TIA (additional examinations, treatment, referral) is not linked to their cardiovascular risk and that the performance of additional examinations and therapies is incomplete.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'Urgences Médico-Chirurgicales Adules - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Mathieu OBERLIN, MD

CONTACT

[email protected]

33 6.72.07.23.60

Mathieu OBERLIN, MD

PRINCIPAL_INVESTIGATOR

Pierrick LE BORGNE, MD

CONTACT

[email protected]

33 3.88.12.86.90

Pierrick LE BORGNE, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (≥18 years old)
  • Having consulted the emergency department or been diagnosed with TIA during the period from January 1, 2024, to December 12, 2024 (records will be compiled via coding at the East Rescue regional emergency observatory)
  • TIA will be defined as a sudden, transient neurological deficit that had disappeared by the time of arrival at the emergency department

Exclusion criteria

  • Subjects with a suspected diagnosis of TIA, i.e., with a sudden, transient neurological deficit that had disappeared by the time of arrival at the emergency department.

Treatment and study plan

Primary outcomes

  1. ABCD2 Score

    Time frame: Up to 12 months

    The ABCD2 score is a medical tool used by doctors after a TIA (Transient Ischemic Attack).

    The total score ranges from 0 to 7:

    • 0-3: low risk
    • 4-5: moderate risk
    • 6-7: high risk

Study contacts

Contact information is provided by the study sponsor or research team.

Mathieu OBERLIN, MD

CONTACT

[email protected]

33 6.72.07.23.60

Pierrick LE BORGNE, MD

CONTACT

[email protected]

33 3.88.12.86.90

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: DAITSU

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jan 14, 2026
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.